The launch is supported by 9 peer-reviewed publications, 12 mode-of-action studies and 5 years of field data, reflecting a broader industry shift toward scientifically validated feed additives.
Novonesis prides itself in having 40 research and development centers and 30 production sites all over the world.
During the 25-year-old partnership, Novonesis was responsible for research, development and production, while dsm-firmenich managed distribution and sales.
As livestock producers across Africa and the Middle East seek alternatives to antibiotic growth promoters, feed probiotics have become an essential tool for improving gut…
This move reflects dsm‑firmenich’s determination to streamline its portfolio and concentrate on higher‑margin consumer markets.
DSM-Firmenich confirmed in early 2024 that it intends to carve out the ANH division by the end of 2025.
As part of its broader portfolio evolution, the company confirmed the ongoing exit from the Animal Nutrition & Health segment is “advancing as planned.”